Bob Hariri

Insider profile

Currently holds positions in Medavail Holdings Inc and Cryoport Inc

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
14 21% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Chairman of the Board Medavail Holdings Inc April 1, 2012 -
Independent Director Cryoport Inc Sept. 25, 2015 -
Independent Director Bionik Laboratories Corp Feb. 26, 2015 - Oct. 3, 2017

Bob Hariri's trades of Cryoport Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
252.57
Quantity 81,830 +4.3%
Value US$4,228,570
Transaction date
Proposed sale
Price
56.54
Quantity 14,228
Value US$3,092,581
Transaction date
Sale
Price
143.54
Quantity 80,718 -0.2%
Value US$4,721,052
Transaction date
Sale
Price
6.10
Quantity 12,500 -60.8%
Value US$76,250
Transaction date
Sale
Price
6.48
Quantity 2,500 -10.8%
Value US$16,200
Transaction date
Sale
Price
9.47
Quantity 1,000 -4.2%
Value US$9,465
Transaction date
Sale
Price
9.00
Quantity 1,000 -4.1%
Value US$9,000
Transaction date
Sale
Price
8.40
Quantity 1,000 -3.9%
Value US$8,395
Transaction date
Sale
Price
16.89
Quantity 800 -5.9%
Value US$13,512
Transaction date
Sale
Price
15.50
Quantity 1,000 -6.9%
Value US$15,500
Transaction date
Proposed sale
Price
15.20
Quantity 1,800
Value US$27,360
Transaction date
Purchase
Price
0.16
Quantity 3,050,427 +12.0%
Value US$483,798
Transaction date
Purchase
Price
0.16
Quantity 6,307,158 +32.8%
Value US$1,000,315
Transaction date
Purchase
Price
0.17
Quantity 9,064,539 +89.3%
Value US$1,500,181
Transaction date
Sale
Price
13.60
Quantity 1,500 -9.4%
Value US$20,400
Transaction date
Purchase
Price
1.72
Quantity 10,000 +0.1%
Value US$17,175
Transaction date
Purchase
Price
1.71
Quantity 40,000 +0.5%
Value US$68,400
Transaction date
Purchase
Price
1.74
Quantity 40,000 +0.5%
Value US$69,600
Transaction date
Sale
Price
43.29
Quantity 2,000 -20.2%
Value US$86,581
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-09-12 2025-09-11 S Sale
81,830 +4.3%
252.57
US$4,228,570
81,830 +4.3% 252.57 US$4,228,570
2025-09-11 2025-09-11 PrS Proposed sale
14,228
56.54
US$3,092,581
14,228 56.54 US$3,092,581
2025-08-29 2025-08-22 S Sale
80,718 -0.2%
143.54
US$4,721,052
80,718 -0.2% 143.54 US$4,721,052
2025-05-30 2025-05-28 S Sale
12,500 -60.8%
6.10
US$76,250
12,500 -60.8% 6.10 US$76,250
2024-12-02 2024-11-21 S Sale
2,500 -10.8%
6.48
US$16,200
2,500 -10.8% 6.48 US$16,200
2024-08-26 2024-08-19 S Sale
1,000 -4.2%
9.47
US$9,465
1,000 -4.2% 9.47 US$9,465
2024-08-20 2024-08-16 S Sale
1,000 -4.1%
9.00
US$9,000
1,000 -4.1% 9.00 US$9,000
2024-08-20 2024-08-14 S Sale
1,000 -3.9%
8.40
US$8,395
1,000 -3.9% 8.40 US$8,395
2023-12-18 2023-12-14 S Sale
800 -5.9%
16.89
US$13,512
800 -5.9% 16.89 US$13,512
2023-12-13 2023-12-11 S Sale
1,000 -6.9%
15.50
US$15,500
1,000 -6.9% 15.50 US$15,500
2023-12-11 2023-12-11 PrS Proposed sale
1,800
15.20
US$27,360
1,800 15.20 US$27,360
2023-10-10 2023-10-05 B Purchase
3,050,427 +12.0%
0.16
US$483,798
3,050,427 +12.0% 0.16 US$483,798
2023-10-10 2023-10-05 B Purchase
6,307,158 +32.8%
0.16
US$1,000,315
6,307,158 +32.8% 0.16 US$1,000,315
2023-10-10 2023-09-29 B Purchase
9,064,539 +89.3%
0.17
US$1,500,181
9,064,539 +89.3% 0.17 US$1,500,181
2023-09-12 2023-09-06 S Sale
1,500 -9.4%
13.60
US$20,400
1,500 -9.4% 13.60 US$20,400
2022-11-30 2022-11-30 B Purchase
10,000 +0.1%
1.72
US$17,175
10,000 +0.1% 1.72 US$17,175
2022-11-29 2022-11-29 B Purchase
40,000 +0.5%
1.71
US$68,400
40,000 +0.5% 1.71 US$68,400
2022-11-28 2022-11-28 B Purchase
40,000 +0.5%
1.74
US$69,600
40,000 +0.5% 1.74 US$69,600
2022-08-16 2022-08-11 S Sale
2,000 -20.2%
43.29
US$86,581
2,000 -20.2% 43.29 US$86,581